TDEE & Weight Loss Timeline Calculator
How many calories you burn per day, how long it’ll take to hit your goal weight, and how that timeline changes if you add a GLP-1 medication. All in one tool.
Most weight loss calculators give you one number — your calorie target — and call it a day. That’s not useful. What you actually want to know is how long it’s going to take, what’s realistic at your starting point, and whether you should be doing this with diet alone or whether a medical option makes sense for your situation.
This calculator answers all three questions. Enter your stats, set your goal weight, and pick your approach. The result shows you the timeline both ways — diet-only and with a GLP-1 medication — side by side.
The math behind the numbers
Two well-validated frameworks feed this calculator, plus published clinical trial data for the GLP-1 projection.
- BMR — Mifflin-St Jeor equation (1990). The most accurate widely-used predictive equation for basal metabolic rate, validated against indirect calorimetry. In a 2005 systematic review comparing four major BMR equations, Mifflin-St Jeor predicted resting metabolic rate within 10% of measured values in more individuals than any competing formula. The Academy of Nutrition and Dietetics designated it the evidence-based standard predictive equation for resting energy expenditure.
- TDEE — Activity multiplier method. Your basal metabolic rate (calories at rest) multiplied by an activity factor (1.2 sedentary to 1.9 very active) gives total daily energy expenditure — the calories you burn in a normal day. This is the number that matters for weight loss math.
- GLP-1 weight loss projection — published clinical trial data. Average weight loss in major GLP-1 randomized trials ranges from roughly 13% (semaglutide STEP trial, 68 weeks) to 20% (tirzepatide SURMOUNT trial, 72 weeks) of starting body weight. We use a conservative midpoint with a range — not a guarantee.
Calculate your TDEE and weight loss timeline
Enter your stats below. The calculator will show your maintenance calories, your timeline to goal weight at a sustainable deficit, and a side-by-side comparison with the GLP-1 trajectory.
Steady & sustainable
—
Faster trajectory
—
A licensed clinician will review whether you qualify, walk through the medication options legally available in your state, and explain expected results in your situation. Telehealth-based. No pressure.
Fasting glucose, HbA1c, lipids, and thyroid markers give you a baseline to measure against. They also reveal underlying issues (insulin resistance, thyroid dysfunction) that affect how weight loss actually plays out.
For educational purposes only. Energy expenditure estimates are based on the Mifflin-St Jeor equation, accurate within approximately 10% for most adults. Weight loss timelines assume linear caloric deficit, which underestimates real-world variability — metabolic adaptation typically slows weight loss as the cut progresses. GLP-1 projections are based on published clinical trial averages and should not be interpreted as guarantees of individual outcomes.
The diet-only path: what to actually expect
Most weight loss content sells you a fantasy version of how the math works. The real version is messier, slower, and more frustrating — and it’s worth knowing that going in.
Calories in vs calories out is technically true, but the equation is unstable
Yes, weight loss requires a calorie deficit. That part isn’t controversial. What the simple version leaves out is that your body actively resists the deficit. As you lose weight, your BMR drops because there’s less of you to maintain. Your TDEE drops because lower-weight movement burns fewer calories. Your body adapts hormonally — ghrelin (the hunger hormone) rises, leptin (the satiety hormone) falls. By month four of a serious cut, you’re typically eating less than you were at the start just to maintain the same deficit, while feeling significantly hungrier.
This is why most diets fail. Not because the math is wrong, but because sustaining the math is psychologically and physiologically punishing.
What a sustainable deficit actually looks like
A 500-calorie daily deficit gives you roughly one pound of weight loss per week. That’s the textbook target. For a 220-pound guy who wants to get to 180, that’s 40 weeks — 10 months — of consistent execution. Aggressive deficits (750 to 1000 calories/day) speed up the timeline on paper, but tend to crash earlier and lose more muscle along the way.
The muscle problem nobody talks about
Roughly 20 to 30 percent of weight lost on a typical caloric deficit is lean body mass — muscle. If you cut hard and don’t train resistance, that number can climb to 40 percent. You can lose 30 pounds and end up looking softer than when you started because the scale dropped but body composition got worse.
The fix is straightforward in theory: adequate protein (around 0.8 to 1 gram per pound of target body weight), resistance training three to four times per week, and a slower deficit. In practice, most guys cutting aggressively don’t do this — and end up frustrated when the result doesn’t match the goal.
The GLP-1 path: what the medication actually does
GLP-1 receptor agonists are a class of medications originally developed for type 2 diabetes that have been shown in major randomized clinical trials to produce significant weight loss in people with obesity or overweight with weight-related conditions. Some are newer dual GLP-1/GIP receptor agonists with even greater effect.
These medications work through several mechanisms that are well established in the literature:
- Slowed gastric emptying. Food stays in your stomach longer. You feel full sooner and stay full longer.
- Appetite signaling at the brain level. GLP-1 receptors in the hypothalamus and brainstem regulate hunger. The medication amplifies satiety signals and reduces the constant background drive to eat.
- “Food noise” reduction. A consistently reported subjective effect — the mental chatter about food, snacks, and cravings drops dramatically for most users.
- Improved insulin sensitivity. A meaningful benefit independent of weight loss, particularly for users with prediabetic markers or metabolic syndrome.
What the clinical data shows
Across major randomized trials in adults with obesity or overweight without diabetes:
- Semaglutide 2.4 mg weekly produced average weight loss of approximately 13 to 15 percent of starting body weight at 68 weeks (STEP-1 trial).
- Tirzepatide 10 to 15 mg weekly produced average weight loss of approximately 19 to 21 percent of starting body weight at 72 weeks (SURMOUNT-1 trial).
- In a head-to-head trial (SURMOUNT-5, published in the New England Journal of Medicine), tirzepatide outperformed semaglutide by approximately 6.5 percentage points of weight loss at 72 weeks.
What the data doesn’t promise
These are population averages from controlled trials. Individual results vary substantially. Some people respond exceptionally well. Others respond modestly. A minority don’t tolerate the medication at all due to gastrointestinal side effects (nausea, vomiting, and diarrhea are the most common). Weight regain after discontinuation is well documented — roughly two-thirds of lost weight typically returns within a year of stopping, which is why ongoing therapy and a sustainable lifestyle component are both important.
Lean mass loss is also a real consideration. In clinical trials, approximately 26 to 40 percent of weight lost on GLP-1 medications was lean body mass — similar to or slightly worse than diet alone. Resistance training and adequate protein during treatment substantially reduce muscle loss, but the effect is real and needs to be planned for.
When GLP-1 makes sense — and when it doesn’t
Not everyone is a candidate for GLP-1 therapy. And not everyone who is a candidate actually needs it. Here’s the honest framework.
This is the FDA-approved indication for chronic weight management. Comorbidities include hypertension, type 2 diabetes, high cholesterol, sleep apnea, and cardiovascular disease. If you fall in this band and have struggled with diet-only approaches, you’re a typical candidate. A consultation determines whether you meet clinical criteria and which medication fits your situation.
This is the gray zone. You don’t have a classic medical indication, but you’ve genuinely tried sustained caloric restriction and it isn’t working — either because of metabolic factors (insulin resistance, hormonal issues, age-related changes), behavioral factors (chronic stress, sleep deprivation, food environment), or some combination. A consultation explores whether your situation warrants medication or whether other interventions should come first.
If you’re already at a healthy weight and want to drop the last 10 to 15 pounds for aesthetics, GLP-1 medications are not the right tool. The risk-benefit balance shifts unfavorably at lower BMIs, and the muscle loss component matters more when there’s less fat to lose. Diet adjustment, resistance training, and protein optimization are the better path for cosmetic body composition work.
A licensed clinician evaluates these factors during your consultation along with your medical history, current medications, and individual response to other interventions. There is no online quiz that can replace that conversation — and the regulatory landscape requires it for a real prescription anyway.
What to do next
Two paths depending on where you are.
Book a GLP-1 consultation
If the numbers in the calculator look interesting and you want to know what’s actually available to you, a consultation is the right next step. The regulatory landscape for GLP-1 medications is changing rapidly — what’s available in your state, what insurance covers, and what compounded options exist all depend on current rules.
- Telehealth-based — no in-person visits required for most patients
- Licensed clinicians who manage weight loss medications full-time
- Reviews your medical history, current medications, and goals
- Explains what’s legally available in your specific state right now
- Ongoing monitoring throughout treatment, not just a one-time prescription
- Transparent pricing — no insurance gymnastics required
Run baseline labs
Before starting any weight loss intervention — diet, GLP-1, or both — getting a metabolic baseline gives you something concrete to measure against. It also catches issues that affect how weight loss plays out, like insulin resistance, thyroid dysfunction, or hormone imbalances that often go undiagnosed for years.
Total testosterone plus a few essentials. Limited metabolic coverage.
Hormone-focused panel — better suited to TRT investigation than to metabolic baseline.
Includes fasting glucose, HbA1c, full lipid panel, thyroid, and metabolic markers — the variables that actually matter for weight loss planning.
For most people pursuing GLP-1, the sequence is: baseline labs first, then consultation. Walking into a consultation with current bloodwork makes the conversation infinitely more useful. But if you don’t want to wait, the consultation can proceed and labs can be ordered as part of the workup.
Frequently asked questions
How accurate is the TDEE calculation?
The Mifflin-St Jeor equation predicts BMR within 10% of measured values for most adults. The activity multiplier introduces additional variability — most people overestimate their activity level, which inflates the TDEE estimate and slows actual weight loss. If you’re new to tracking, start with the calculated number and adjust based on real-world results over two to three weeks. If you’re not losing weight at the projected pace, your true TDEE is probably 5 to 15% lower than the estimate.
Why does weight loss slow down over time?
Three reasons. First, your BMR drops as you lose weight because there’s less of you to maintain. Second, your TDEE drops because everyday movement burns fewer calories at a lower body weight. Third, the body adapts hormonally — ghrelin rises, leptin falls, and you feel hungrier on the same calorie intake. This is called metabolic adaptation and it’s why a 500-calorie deficit that produced one pound per week in month one might only produce half a pound per week by month four. Building a steeper deficit isn’t the right response — it accelerates the adaptation. The right responses are protein, resistance training, and patience.
How much weight loss can I expect on a GLP-1 medication?
Major clinical trials in adults with obesity or overweight have shown average weight loss of approximately 13 to 21 percent of starting body weight over 68 to 72 weeks, depending on the specific medication and dose. Individual results vary significantly — some people respond exceptionally well, others modestly. The calculator uses a midpoint estimate (around 17 percent) with a range. Your actual outcome depends on the medication prescribed, your dose, your duration of therapy, your lifestyle during treatment, and individual physiological response.
What happens when I stop taking the medication?
Weight regain after discontinuation is well documented. Approximately two-thirds of lost weight typically returns within a year of stopping. This is why GLP-1 therapy is generally considered chronic — like a medication for high blood pressure or cholesterol, the underlying biology doesn’t change just because you’ve reached your goal weight. People who successfully maintain their loss after stopping tend to be those who used the medication as a tool to establish sustainable eating and exercise habits, then transitioned off gradually with continued lifestyle support.
Will I lose muscle on a GLP-1 medication?
Yes — but not necessarily more than you’d lose on a diet alone. In clinical trials, approximately 26 to 40 percent of weight lost on GLP-1 medications was lean body mass. Diet-only weight loss typically produces 20 to 30 percent lean mass loss. The strategies for minimizing muscle loss are the same in both cases: adequate protein intake (around 0.8 to 1 gram per pound of target body weight), resistance training 3 to 4 times per week, and avoiding excessive caloric deficits.
What are the side effects of GLP-1 medications?
Gastrointestinal side effects are the most common: nausea, vomiting, diarrhea, and constipation. These typically improve as the body adapts to the medication and as doses are titrated. Most people tolerate well at lower doses and develop tolerance over weeks. A minority of patients don’t tolerate the medication at all and need to discontinue. Less common but more serious risks include pancreatitis, gallbladder issues, and potential thyroid concerns — these are discussed in detail during a clinical consultation. The medication is not appropriate for everyone, which is why a clinical evaluation is required.
Should I do TRT and GLP-1 at the same time?
For men with both low testosterone and obesity, combined therapy is increasingly common in optimization-focused practices. Low testosterone makes fat loss harder and muscle preservation more difficult. GLP-1 medications drive significant weight loss but contribute to muscle loss. Combining them often produces better body composition outcomes than either alone — testosterone preserves lean mass while the GLP-1 drives the fat loss. Whether this combination is right for you depends on your numbers, your symptoms, and your goals. A clinician familiar with both protocols is the right person to evaluate the fit.
Does this calculator save my data?
No. Your inputs exist only in your browser session. We don’t store them, log them, or attach them to your account if you have one. You can run the calculator as many times as you want without anything being saved on our end.
The numbers are the easy part.
Knowing your TDEE and your timeline is useful. Knowing which path to actually take is harder — and depends on details a calculator can’t see. If GLP-1 looks like something worth exploring for your situation, a consultation is the right next step. If you want to start with bloodwork to know exactly what’s going on metabolically before making any decisions, that’s also a good move.
This calculator and the information on this page are for educational purposes only. The Mifflin-St Jeor equation produces BMR estimates accurate within roughly 10% for most adults; individual variation exists. GLP-1 projections are based on published clinical trial averages and are not guarantees of individual outcomes. Weight loss medications are prescription products that require evaluation by a licensed clinician. The regulatory landscape for GLP-1 medications is evolving — availability, formulation options, and insurance coverage vary by state and change frequently.